Skip to main content
OpenTrials

Clinical trial condition

Adult Giant Cell Glioblastoma

Explore clinical trials studying Adult Giant Cell Glioblastoma. Study availability and eligibility vary by location and protocol.

53 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adult Giant Cell Glioblastoma trial results

Completed

Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

NCT00423735

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Scottsdale, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
View all 188 locations
View Trial Details
Completed

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00902577

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Completed

Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

NCT00335764

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

NCT01648348

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Saint Jude Medical Center Fullerton, California, United States
  • Saint Joseph Hospital - Orange Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 308 locations
View Trial Details
Completed

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

NCT00305864

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +11 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Arizona Oncology Services Foundation Scottsdale, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
View all 106 locations
View Trial Details

Related conditions